Anti Obesity Drugs Market By Product Type(Peripherally acting anti-obesity agents, Centrally acting anti-obesity drugs) By End User(Hospitals, Vendors) and Region – Global Forecast to 2024
Anti-obesity drugs are used to control body weight either by reducing appetite or absorption of calories.
The global anti-obesity drug market is anticipated to grow at compound annual growth rate (CAGR) of 40.0 percent over the period of 2015-2020. Geographically, the global anti-obesity drug market is segmented into North America, Latin America, Western and Eastern Europe, Asia-Pacific and Rest of World.
Growth Drivers and challenges
Prevailed bad eating habits, steep growth in packaged food consumption, less physical activity and hereditary concerns are the biggest factor in the increased obese people. Rising concern of health problems related to obesity, presence of large numbers of obese people around the globe and change in lifestyle are the major growth drivers of global anti-obesity drug market.
For Sample Pages please go through link below: https://www.researchnester.com/sample-request/2/rep-id-23
Global anti-obesity drug market faces some of major challenges like high cost involved in research and development, side effects of anti-obesity drugs, and rising popularities of other alternatives (fitness spas, therapies, etc.) to reduce obesity.
Market Size and Forecast
Regionally, North America anti-obesity drug market is forecasted to have a burgeoned growth during the forecast period i.e. 2015-2021. The market is likely to get propelled owing to rising cases of obesity, expanding healthcare industry and various government initiatives to curb obesity problems.
Europe anti-obesity drug market is also expected to witness a steady growth owing to rising cases of diabetes (which is majorly caused due to obesity) in some of the major European countries such as Germany, Spain, Italy, France and the U.K.
Request For TOC Here:–https://www.researchnester.com/toc-request/1/rep-id-23
Asia-Pacific anti-obesity drug market is anticipated to bolster backed up by improvements in the healthcare sector and increase in disposable income. India and China are two major anti-obesity drug markets in Asia-Pacific region.
The major players of global anti-obesity drug market are mentioned as below: Arena Pharmaceuticals Inc., F. Hoffmann-La Roche Ag, Glaxosmithkline Plc, Takeda Pharmaceuticals Company Limited, Zafgen, ZydusCadila, Rhythm Pharmaceuticals, Pfizer Inc., Merck & Co. Inc., Orexigen Therapeutics Inc., BoehringerIngelheimGmbh, Eisai Co. Ltd., Novo Nordisk A/S, Norgine B.V.
To Know More About This Research, Kindly Visit: https://www.researchnester.com/reports/anti-obesity-drugs-market-global-demand-analysis-opportunity-outlook-2021/23
For Table of Content & Free Sample Report Contact:
U.S. +1 646 586 9123
U.K. +44 203 608 5919